Prevalence of fibromyalgia and associated factors in Spain.
Por:
Font Gayà T, Bordoy Ferrer C, Juan Mas A, Seoane-Mato D, Álvarez Reyes F, Delgado Sánchez M, Martínez Dubois C, Sánchez-Fernández SA, Marena Rojas Vargas L, García Morales PV, Olivé A, Rubio Muñoz P, Larrosa M, Navarro Ricós N, Sánchez-Piedra C, Díaz-González F and Bustabad-Reyes S
Publicada:
8 ene 2020
Ahead of Print:
8 ene 2020
Resumen:
OBJECTIVES: The prevalence of fibromyalgia (FM) differs depending on the population studied. The main objective of the EPISER2016 study was to estimate the prevalence of FM in adults in Spain. The secondary objective was to evaluate the association with sociodemographic and anthropometric characteristics and smoking. METHODS: This is a population-based cross-sectional multicentre study. The random selection was based on multistage stratified cluster sampling. The final sample comprised 4916 persons aged =20 years. Participants were contacted by telephone for completion of a screening survey. Investigating rheumatologists evaluated positive results (review of medical records and/or telephone interview, with medical visit if needed) to confirm the diagnosis. Prevalence and 95% confidence interval were calculated, taking into account the sample design. Weighing was applied based on age, sex, and geographic origin. Predictive models were constructed to analyse which sociodemographic, anthropometric and lifestyle variables in the call centre questionnaire were associated with the presence of FM. RESULTS: 602 subjects (12.25%) had a positive screening result for FM, of which 24 were missing (3.99%). A total of 141 cases of FM were recorded. The estimated prevalence was 2.45% (95% CI, 2.06-2.90). Female sex was the variable most associated with FM, with an odds ratio (OR) of 10.156 (95% CI, 5.068-20.352). Peak prevalence was at 60-69 years (p=0.009, OR=6.962). FM was 68% more frequent in obese individuals (OR, 1.689; 95% CI, 1.036-2.755). CONCLUSIONS: The prevalence of FM in adults in Spain barely changed between 2000 and 2016 and it is similar to that observed in Europe as a whole.
Filiaciones:
Font Gayà T:
Rheumatology, Hospital Comarcal de Inca, Baleares, Spain
Bordoy Ferrer C:
Rheumatology, Hospital Comarcal de Inca, Baleares, Spain
Juan Mas A:
Rheumatology, Hospital Son Llàtzer, Palma de Mallorca, Baleares, Spain.
Seoane-Mato D:
Research Unit, Spanish Society of Rheumatology, Madrid, Spain
Álvarez Reyes F:
Rheumatology, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain
Delgado Sánchez M:
Rheumatology, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain
Martínez Dubois C:
Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Sánchez-Fernández SA:
Rheumatology, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain
Marena Rojas Vargas L:
Rheumatology, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain
García Morales PV:
Rheumatology, Complejo Hospitalario Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain
:
Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
Rubio Muñoz P:
Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
Larrosa M:
Rheumatology, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain
Navarro Ricós N:
Rheumatology, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain
Sánchez-Piedra C:
Research Unit, Spanish Society of Rheumatology, Madrid, Spain
Díaz-González F:
Rheumatology, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife
and Universidad de La Laguna, Departamento de Medicina Interna, Dermatología y Psiquiatría, La Laguna, Santa Cruz de Tenerife, Spain
Bustabad-Reyes S:
Rheumatology, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain
|